Investigating in vitro and in vivo avß6 integrin receptor-targeting liposomal alendronate for combinatory ?d T cell immunotherapy. (2017)

First Author: Hodgins NO
Attributed to:  Shuttling through the Blood Brain Barrier using Carbon Nanoneedles funded by BBSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.jconrel.2017.04.025

PubMed Identifier: 28432037

Publication URI: http://europepmc.org/abstract/MED/28432037

Type: Journal Article/Review

Volume: 256

Parent Publication: Journal of controlled release : official journal of the Controlled Release Society

ISSN: 0168-3659